Optimal first-line treatment strategies of systemic therapy for unresectable gastrointestinal neuroendocrine tumors based on the opinions of Japanese experts. Yoshitaka HonmaMasafumi IkedaJunji Furuse Brief Report 19 October 2023 Pages: 777 - 786
Gefitinib, an effective treatment option for patients with pulmonary enteric adenocarcinoma harboring compound EGFR L858R and A871G mutation Yujie CuiJinlong LiangHongzhen Zhang Case Report 13 October 2023 Pages: 787 - 790
Antitumor activity of the new tyrphostin briva against BRAFV600E-mutant colorectal carcinoma cells Khaled SalehMai Al SakhenBernhard Biersack Research 23 October 2023 Pages: 791 - 801
Clinical characterization, treatment, and outcome of nivolumab-induced bullous pemphigoid Miao LiuMaoye YuanChunjiang Wang Research 29 September 2023 Pages: 802 - 807
Pharmacokinetics, pharmacodynamics and efficacy of pemigatinib (a selective inhibitor of fibroblast growth factor receptor 1–3) monotherapy in Chinese patients with advanced solid tumors: a phase i clinical trial Ting DengLe ZhangYi Ba Research Open access 27 October 2023 Pages: 808 - 815
Clinical characteristics and prognostic impact of immune checkpoint inhibitor-associated myocarditis in advanced non-small cell lung cancer Lan XuManyi XuZhengbo Song Research 30 October 2023 Pages: 816 - 824
Therapeutic effectiveness of anlotinib combined with etoposide in extensive-stage small-cell lung cancer: a single-arm, phase II trial Yuan WuXuefeng ZhouBo Shen Research Open access 14 October 2023 Pages: 825 - 833
Clinical characteristics, treatment, and management of pembrolizumab induced hemophagocytic lymphohistiocytosis Chunjiang WangWei SunWeijin Fang Research 28 October 2023 Pages: 834 - 841
The ATR inhibitor berzosertib acts as a radio- and chemosensitizer in head and neck squamous cell carcinoma cell lines Julia SchnoellCarmen SparrBernhard J. Jank Research Open access 07 November 2023 Pages: 842 - 850
Phase 1/1b open-label, dose-escalation study of fruquintinib in patients with advanced solid tumors in the United States Andrea Wang-GillamWilliam SchelmanHeather Yeckes-Rodin Research Open access 05 October 2023 Pages: 851 - 860
Gastrointestinal signet ring cell malignancy: current advancement and future prospects Weiping HongQingjun HuDa Wang Review 21 October 2023 Pages: 861 - 869